2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$3.63-$0.32 (-8.10%)
Price as of Oct 02, 2026 6:02 PM EDT- $7.7MMarket Cap
- -99.63%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$3.63-$0.32 (-8.10%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.95 | ||
Change | -$0.55 (-12.22%) | ||
Open | $4.34 | ||
High | $4.48 | ||
Low | $3.82 | ||
Previous Close | $4.50 | ||
Volume | 471,265 | ||
30-Day Average Volume | 3,486,388 | ||
1-Week Change | -44.05% | ||
1-Month Change | -63.98% | ||
1-Year Change | -99.63% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 1.9M | ||
Total Assets | $34.2M | ||
Market Cap | $7.7M | ||
Enterprise Value | $19.5M | ||
Period: QTR TTM FY | |||
Revenue | $43,000.00 | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$12.6M | ||
EBITDA | -$12.2M | ||
Net Working Capital | -$7.8M | ||
EPS | -$235.50 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 452 | ||
P/B | 2 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 09/17/2026 | ||
Earnings & Revenue